This inventor holds 1 USPTO granted patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: The Innovations of Bruce B. Mason in Vaccine Development
Introduction
Bruce B. Mason is a noteworthy inventor based in Downington, PA, recognized for his contributions to the field of vaccine development. He has a significant patent under his name, which focuses on the sequence analysis of the tetravalent rotavirus vaccine. His work has the potential to enhance the efficacy and safety of vaccines, playing a crucial role in public health.
Latest Patents
Mason holds one patent titled "Sequence analysis of the tetravalent rotavirus vaccine". This patent discloses isolated nucleic acid molecules that include gene segments from a rhesus rotavirus (RRV) and three rhesus-human reassortant viruses. The patent highlights isolated nucleic acid molecules having sequences from SEQ ID NO: 1-14, as well as those encoding proteins with sequences from SEQ ID NO: 15-28. This innovation also encompasses variants of these isolated nucleic acid molecules, showcasing Mason's dedication to advancing medical technology.
Career Highlights
Bruce B. Mason is affiliated with the United States of America as represented by the Department of Health and Human Services. His career reflects a commitment to enhancing public health through innovative research and development. Mason's solitary patent underscores his expertise and significant impact in his field, contributing to the understanding of rotavirus and advancing vaccine technology.
Collaborations
In his professional journey, Bruce B. Mason has collaborated with notable colleagues such as Deborah A. Buonagurio and Alice F. Georgiu. These collaborations illustrate the teamwork and collective effort often required in research and innovations in the biomedical field, reinforcing the importance of shared knowledge and resources in achieving scientific breakthroughs.
Conclusion
Bruce B. Mason's contributions to vaccine innovation exemplify the vital role of inventors in addressing public health challenges. His patent on the tetravalent rotavirus vaccine represents a significant advancement in vaccine research, aiming to provide safer and more effective healthcare solutions. Through his career and collaborations, Mason continues to make strides in the field, showcasing the importance of innovation in medicine.